Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease

Arthritis Rheum. 2007 Dec 15;57(8):1530-8. doi: 10.1002/art.23088.

Abstract

Objective: To determine spontaneous and activation-induced apoptosis of peripheral blood lymphocytes (PBLs) from patients with active untreated adult-onset Still's disease (AOSD) and to examine the role of interleukin-18 (IL-18) involved in the apoptosis related to this disease.

Methods: The percentages of spontaneous and IL-18-stimulated apoptotic lymphocytes in peripheral blood of 20 patients with active untreated AOSD, 20 with active untreated systemic lupus erythematosus (SLE), and 20 healthy controls were determined using annexin V/propidium iodide staining and flow cytometry. Serum IL-18 levels were measured using enzyme-linked immunosorbent assay. The transcripts of caspase 3 gene and apoptosis-regulating genes, including Fas, FasL, Bcl-2, and p53 in IL-18-treated peripheral blood mononuclear cells (PBMCs) from 8 AOSD patients, 4 SLE patients, and 4 healthy controls, were examined by real-time quantitative polymerase chain reaction.

Results: Significantly higher percentages of spontaneous and IL-18-stimulated apoptotic PBLs were found in patients with active untreated AOSD and those with active untreated SLE than in healthy controls. The percentages of spontaneous and IL-18-stimulated apoptotic lymphocytes correlated positively with clinical activity scores and serum IL-18 levels for AOSD patients and SLE patients. The percentages of spontaneous and activation-induced apoptotic PBLs significantly declined, paralleling clinical remission and the decrease in serum IL-18 levels after effective therapy in AOSD patients. Up-regulation of FasL and p53 transcripts was demonstrated in IL-18-treated PBMCs from AOSD patients and SLE patients in a dose-dependent manner.

Conclusion: The increased apoptosis of PBLs from AOSD patients may be associated with the effect of IL-18 through up-regulation of FasL and p53 transcripts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Case-Control Studies
  • Caspase 3 / metabolism
  • Dose-Response Relationship, Drug
  • Fas Ligand Protein / metabolism
  • Fas-Associated Death Domain Protein / metabolism
  • Female
  • Humans
  • Interleukin-18 / blood*
  • Interleukin-18 / physiology
  • Lupus Erythematosus, Systemic / blood
  • Lupus Erythematosus, Systemic / pathology
  • Lymphocytes / metabolism
  • Lymphocytes / pathology*
  • Male
  • Middle Aged
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • RNA, Messenger / metabolism
  • Recombinant Proteins / pharmacology
  • Still's Disease, Adult-Onset / blood*
  • Still's Disease, Adult-Onset / etiology
  • Still's Disease, Adult-Onset / pathology
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Fas Ligand Protein
  • Fas-Associated Death Domain Protein
  • Interleukin-18
  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Messenger
  • Recombinant Proteins
  • Tumor Suppressor Protein p53
  • Caspase 3